In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...
Dec 27, 2022
0
107
A Northwestern Medicine study has discovered that elevated PALI1 in advanced prostate tumors mediates crosstalk between two primary epigenetic silencing mechanisms, suggesting that dual epigenetic inhibition may be an effective ...
Dec 21, 2022
0
54
Autoimmune diseases are thought to be the result of mistaken identity. Immune cells on patrol, armed and ready to defend the body against invading pathogens, mistake normal human cells for infected cells and turn their weapons ...
Dec 7, 2022
1
319
Research led by Randal J. Kaufman, Ph.D., has found that misfolded proteins in liver cells contribute to the development of liver cancer, shedding new light on the mysterious origins of one of the world's deadliest diseases. ...
Dec 7, 2022
0
47
A decrease in protein synthesis in the cells of the developing gut contributes to a rare genetic disorder, and an inexpensive nutritional supplement may help reverse that decrease, according to a new study by Yun-Fei Li of ...
Nov 1, 2022
1
820
Researchers have developed a system which uses light stimulation to modulate brain waves. This opens up new avenues to explore for possible treatment of conditions such as epilepsy, Parkinson's and migraine.
Oct 21, 2022
0
102
Scientists at Scripps Research have developed a new tool to monitor brain plasticity—the way our brains remodel and physically adapt as we learn and experience things, from watching a movie to learning a new song or language. ...
Oct 19, 2022
0
243
Many changes take place in the brain long before symptoms appear. This has been shown in mice in two studies of prion diseases in which the brain gradually deteriorates. The results suggest that changes can be studied extremely ...
Oct 10, 2022
0
51
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
Researchers from the Institute of Biotechnology, University of Helsinki, pioneers in identifying the first patient mutations on the NFkB1-gene, cooperated with international clinicians to identify and characterize a plethora ...
Sep 20, 2022
0
74
